QNRX - Quoin Pharmaceuticals Ltd DRC
Quoin Pharmaceuticals Ltd DRC Logo

QNRX - Quoin Pharmaceuticals Ltd DRC

https://quoinpharma.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

None

52W High
$37.80
52W Low
$5.01

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.85
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
0.01
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.42
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
1.74
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
0.20%
Institutions (25–75% balanced)
0.16%
Shares Outstanding
588,170
Float
4,128,100
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
958.65
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-2.43%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.0074
Previous
-0.0217
Trend
Rising
Signal Cross
No cross

As of
Sep. 12, 2025